The Recall Desk
Agency classClass IIOur severity:HighFDA (Devices)·Z-0091-2013·Announced 2012-10-24

Osteotech Recalls Grafton and Xpanse Bone Graft Products Due to Sterility Concerns

Osteotech is recalling multiple lots of Grafton and Xpanse bone graft products because the sterility of the inner pouch surface may be compromised.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a potential sterility failure in a medical device used for bone grafting, which poses a risk of infection (harm) even though no specific injuries or illnesses are reported in the source text.

Plain-English summary

Osteotech Inc is recalling multiple lots of Grafton and Xpanse, which are human bone allograft products used for bone grafting procedures. The recall is being conducted because there is a possibility that the sterility of the outer surface of the inner pouch may become compromised.

The affected products are distributed worldwide, including nationwide in the United States and internationally. The specific lots involved are detailed in an attachment referenced in the recall notice.

Healthcare providers and patients should stop using the affected lots of Grafton and Xpanse and contact Osteotech Inc for further instructions or a replacement.

The recalled product

Product
Grafton DBM Orthoblend Large Defect Multiple Sizes Grafton is a human bone allograft product containing demineralized human bone tissue combined with inert additive to yield a demineralized bone matrix (DBM) allograft. It is intended for use as a bone graft extender, bone…
Manufacturer
Osteotech Inc
Affected units
1,274

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Multiple Lots - please see attachment

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 12 recalled by Osteotech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 12 products in this recall →

Similar recalls